Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era

BackgroundElderly patients diagnosed with diffuse large B-cell lymphoma (DLBCL) undergoing reduced intensity R-CHOP therapy are at a heightened risk of acquiring infections, notably coronavirus disease 2019 (COVID-19) infection. This study aimed to evaluate the efficacy of intravenous immunoglobulin...

Description complète

Détails bibliographiques

Auteurs principaux:	Dong Won Baek, Ga-Young Song, Ho Sup Lee, Young Rok Do, Ji Hyun Lee, Ho-Young Yhim, Joon Ho Moon, Deok-Hwan Yang
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2024-04-01
Collection:	Frontiers in Oncology
Sujets:	COVID-19 diffuse large B-cell lymphoma elderly hypogammaglobulinemia immunochemotherapy
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1380492/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!